Navigation Links
Group B Strep Screening Guidelines Sparing Newborns
Date:6/17/2009

More expectant moms being checked, treated so babies aren't infected, study finds

WEDNESDAY, June 17 (HealthDay News) -- Recommendations implemented in 2002 to screen all pregnant women for group B streptococcal disease have largely been successful, a new report shows.

Eighty-five percent of women in the United States are now being screened and, if positive, given appropriate treatment.

"This paper highlights an important public health success story," said study author Melissa K. Van Dyke, who was an epidemic intelligence service officer at the U.S. Centers for Disease Control and Prevention while conducting the study. "Recommendations for universal antenatal screening were rapidly adopted, and this corresponded with further declines in the incidence of early-onset GBS [group B strep] disease."

Van Dyke is now an epidemiologist at GlaxoSmithKline Biologicals in Rixensart, Belgium, although that company played no part in this study, which appears in the June 18 issue of the New England Journal of Medicine.

"These guidelines have been in place for many years now, and this study was asking whether these guidelines had actually had an impact on care, whether people's behavior had changed," added Dr. James M. Greenberg, director of neonatology at the Cincinnati Children's Hospital Medical Center. "And the answer is yes. Women are getting screened now in much higher percentages, they're getting treated and that has led to a reduction in disease in newborns."

GBS is bacteria that, according to the CDC, became the leading infectious cause of illness and death in newborns in the 1970s. GBS can cause sepsis, meningitis and pneumonia in infants, usually within the first week of life. If a pregnant woman is a carrier, the infection can be passed to her child during delivery.

The guidelines recommend that women get screened at 35 weeks to 37 weeks of pregnancy.

"If a mother is p
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. AMERIGROUP Corporation to Present at the 19th Annual Wachovia Mid-Year Equity Conference on June 24
2. Group Health Cooperative Shows Investing in More Primary Care Pays for Itself
3. Group Health Cooperative shows investing in more primary care pays for itself
4. Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
5. BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port-Industry Group and PRSA's Detroit Chapter
6. John Hancock Announces Enhancements to Group Long-Term Care (LTC) Insurance Products and Discount Program
7. A. M. Best Upgrades ProAssurance Group to A (Excellent)
8. Watson to Acquire Arrow Group
9. Linwood Group Research Suggests 3 Questions Everyone Should Ask When Choosing an Alcoholic Residential Centre
10. AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure
11. Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Group B Strep Screening Guidelines Sparing Newborns
(Date:3/1/2015)... Barrel Mill ” was featured on NewsWatch as part of ... latest and coolest technology products and services available to consumers. ... conducted the review and shared with viewers how this oak ... Distillation of Alcohol, it's understood that oak is essential for ... that’ll help anyone achieve a barrel aged alcohol without having ...
(Date:2/28/2015)... In recent years Medical Marijuana has continuously ... as a way for them to expand their patient base ... medicine. Since the FDA still lists Cannabis as a Schedule ... licensed physicians that can help guide them when recommending ... in Santa Cruz, CA is a leader in the ...
(Date:2/28/2015)... 28, 2015 With their commitment to ... added an additional exercise to their already robust library ... is most commonly known as, is often performed on ... are executed in a relatively safe manner and can ... levels. The full description of “Rope Pulls” is located ...
(Date:2/28/2015)... February 28, 2015 Mew and Company, ... that they now provide business consulting services in addition ... corporate tax planning and succession planning. Company finances are ... experienced professionals. On top of this, complex Canadian tax ... corporate accounting. As a result, Mew and Company works ...
(Date:2/28/2015)... MD (PRWEB) February 28, 2015 For ... conference in person, the Mesothelioma Applied Research Foundation ... place on Tuesday, March 3, starting at 9:30 AM. ... requires no registration. The broadcast can be accessed through ... http://www.curemeso.org/symposium . , The Symposium is a unique ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2
... to prevent heart failure, stroke , WEDNESDAY, Nov. ... status as the best first-line treatment in older ... research concludes. , The thiazide-type diuretic chlorthalidone outshone ... an ACE inhibitor and an alpha-receptor blocker -- ...
... to Release Statewide Data , HARRISBURG, Pa., Nov. 18 Pennsylvania ... children and adults living with autism, according to the Pennsylvania Autism ... , "With the release of this report, Pennsylvania becomes the ... prepare to meet the needs of the rapidly growing population of ...
... , CLEVELAND, Nov. 18 Hospice workers have seen patients ... them. Researchers from the Frances Payne Bolton School of Nursing ... Reserve University will study what drives the dying to resolve ... Mary Jo Prince-Paul from nursing and Julie Exline from arts ...
... captures insects, an innovative new device with nano-sized features developed ... in the blood that have broken off from a tumor. ... tumor cells, or CTCs, can provide critical information for examining ... effectiveness of therapies. Metastasis ...
... common surgical painkillers help cancer cells thrive , WEDNESDAY, ... to growing evidence that morphine and other opiate-based painkillers ... , The papers, scheduled to be presented Wednesday at ... preventing opiates from reaching lung cancer cells reduces cancer ...
... ... Organization is asking for nominations for the 2010 Innovations in Healthcare(SM) ABBY ... Event, on April 28, 2010, in Newport Beach, California. At this event, ... of the toughest problems facing healthcare today, and three will take home ...
Cached Medicine News:Health News:Diuretics Still Best Treatment for High Blood Pressure 2Health News:PA Governor Rendell: New Report Shows Demand for Autism Services will Continue to Rise 2Health News:Research Collaboration Focuses on Unfinished Business at the End of Life 2Health News:UCLA researchers create 'fly paper' to capture circulating cancer cells 2Health News:UCLA researchers create 'fly paper' to capture circulating cancer cells 3Health News:Morphine May Help Tumors Spread in Cancer Patients 2Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 2Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 3Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 4
(Date:2/27/2015)... ON , Feb. 27, 2015 /CNW/ - Covalon Technologies ... medical technologies company, today announced financial results for its ... For the three months ended December 31, 2014, revenue ... the quarter was $229,820 or $0.02 per share.  ... , said "I am very pleased with the significant ...
(Date:2/27/2015)... 27, 2015  Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... Officer, will present live at VirtualInvestorConferences.com on March ... join us for this Company update," said Mr. ... commercial launch of the exVive3D Liver, Bioprinted Human ...
(Date:2/27/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a ... proprietary products to treat voiding dysfunctions, today announced that ... on Tuesday, March 10, 2015. Rob Kill , ... Financial Officer, will present at 4:00 p.m. Pacific Time ... conference at the Ritz Carlton in Laguna ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Uroplasty to Participate in the 27th Annual ROTH Conference 2
... KENILWORTH, N.J., Dec. 17 Schering-Plough,Corporation (NYSE: ... that,demonstrated that Asenapine, a fast-dissolving, sublingual tablet being,developed ... placebo,and well tolerated in treating patients with acute ... mg twice daily and 10 mg twice,daily were ...
... Company Initiates Phase1b/2 Clinical Trial in Breast ... PLAINFIELD, N.J., Dec. 17 PTC,Therapeutics, Inc. ... development, and commercialization of small-molecule drugs,targeting post-transcriptional ... Phase 1 data regarding PTC299, its novel,internally ...
Cached Medicine Technology:New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 2New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 3New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 4PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 2PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 3PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: